title: Opioids and immune modulation: more questions than answers.
abstract: Opioid addicts are more likely to present with infections suggesting opioids are immune modulators. The potential sites/mechanism(s) for this modulation are controversial and on close inspection not well supported by the current literature. It has long been assumed that opioid-induced immune modulation occurs via a combination of direct actions on the immune cell itself, via the hypothalamic-pituitary-adrenal (HPA) axis, or both. Opioid receptors are classified as MOP (μ, mu), DOP (δ, delta), and KOP (κ, kappa)--classical naloxone sensitive receptors--or NOP (the receptor for nociceptin/orphanin FQ), which is naloxone insensitive. Opioids currently used in clinical practice predominantly target the MOP receptor. There do not appear to be classical opioid receptors present on immune cells. The evidence for HPA activation is also poor and shows some species dependence. Most opioids used clinically or as drugs of abuse do not target the NOP receptor. Other possible target sites for immune modulation include the sympathetic nervous system and central sites. We are currently unable to accurately define the cellular target for immune modulation and suggest further investigation is required. Based on the differences observed when comparing studies in laboratory animals and those performed in humans we suggest that further studies in the clinical setting are needed.
authors.affiliation: Department of Cardiovascular Sciences, University of Leicester, Division of Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary, Leicester, LE1 5WW, UK.
authors.forename: M
authors.initials: M
authors.lastname: Al-Hashimi
authors.forename: S W M
authors.initials: SW
authors.lastname: Scott
authors.forename: J P
authors.initials: JP
authors.lastname: Thompson
authors.forename: D G
authors.initials: DG
authors.lastname: Lambert
mesh_terms: D000701:Analgesics, Opioid / Q000276:immunology* / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000276:immunology; D056747:Immunomodulation / Q000187:drug effects* / Q000276:immunology*; D023421:Models, Animal; D010913:Pituitary-Adrenal System / Q000187:drug effects / Q000276:immunology; D011957:Receptors, Opioid / Q000187:drug effects* / Q000276:immunology*
chemical_list: D000701:Analgesics, Opioid; D011957:Receptors, Opioid
keywords: HPA axis; immunomodulation; opioid receptors